Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Delcath Systems, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
DCTH
Nasdaq
2836
www.delcath.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Delcath Systems, Inc.
Is the Options Market Predicting a Spike in Delcath Systems Stock?
- Jul 17th, 2025 6:32 am
Loss-Making Delcath Systems, Inc. (NASDAQ:DCTH) Set To Breakeven
- Jun 24th, 2025 4:11 am
Delcath Systems Issues Full Year 2025 Guidance
- May 22nd, 2025 5:00 am
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
- May 15th, 2025 2:30 pm
Delcath Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
- May 11th, 2025 6:31 am
Delcath Systems First Quarter 2025 Earnings: Beats Expectations
- May 10th, 2025 6:08 am
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- May 9th, 2025 3:30 pm
Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
- May 9th, 2025 1:15 am
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
- May 8th, 2025 5:30 am
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer
- Apr 28th, 2025 6:30 am
Delcath Systems to Host First Quarter 2025 Earnings Call
- Apr 24th, 2025 2:01 pm
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
- Apr 9th, 2025 3:00 pm
Beta Bionics Announces Board Appointment of Gerard Michel
- Mar 27th, 2025 2:45 pm
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference
- Mar 24th, 2025 2:01 pm
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 14th, 2025 2:01 pm
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
- Mar 8th, 2025 6:37 am
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation
- Mar 7th, 2025 3:26 am
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
- Mar 6th, 2025 6:00 am
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call
- Feb 20th, 2025 6:30 am
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
- Feb 14th, 2025 6:30 am
Scroll